Eric Easom, Chief Executive Officer at AN2 Therapeutics, Inc. (ANTX), sold 27,277 shares at $15.41 ($426K) on 2022-11-08, disclosed to the SEC on 2022-11-09.
Open-market sale of $426k ANTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.41 | 5,800 | $89K | 21.0% |
| 2 | $16.38 | 1,255 | $21K | 4.8% |
| 3 | $15.61 | 10,111 | $158K | 37.1% |
| 4 | $15.61 | 10,111 | $158K | 37.1% |
| Total | $15.60 avg | 27,277 | $426K | 100% |
| Filing → |
| ANTX | SELL | 2024-01-04 | $112K | — | Filing → |
| ANTX | BUY | 2023-05-15 | $54K | — | Filing → |
| ANTX | SELL | 2022-11-14 | $136K | — | Filing → |